Literature DB >> 15940669

Structural and functional differences between the promoters of independently expressed killer cell Ig-like receptors.

Jeroen van Bergen1, C Andrew Stewart, Peter J van den Elsen, John Trowsdale.   

Abstract

Killer Ig-like receptors (KIR) are important for the recognition and elimination of diseased cells by human NK cells. Myeloid leukemia patients given a hematopoietic stem cell transplantation, for example, benefit from KIR-mediated NK alloreactivity directed against the leukemia cells. To establish an effective NK cell repertoire, most KIR genes are expressed stochastically, independently of the others. However, the sequences upstream of the coding regions of these KIR genes are highly homologous to the recently identified KIR3DL1 promoter (91.1-99.6% sequence identity), suggesting that they are regulated by similar if not identical mechanisms of transcriptional activation. We investigated the effects of small sequence differences between the KIR3DL1 promoter and other KIR promoters on transcription factor binding and promoter activity. Surprisingly, electrophoretic mobility shift assays and promoter-reporter assays revealed significant structural and functional differences in the cis-acting elements of these highly homologous KIR promoters, suggesting a key role for transcription factors in independent control of expression of specific KIR loci. Thus, the KIR repertoire may be shaped by a combination of both gene-specific and stochastic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940669     DOI: 10.1002/eji.200526201

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

Review 1.  The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.

Authors:  Jeroen van Bergen; Frits Koning
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

2.  Promoter variants of KIR2DL5 add to diversity and may impact gene expression.

Authors:  Tiernan J Mulrooney; LiHua Hou; Noriko K Steiner; Minghua Chen; Ian Belle; Jennifer Ng; Carolyn Katovich Hurley
Journal:  Immunogenetics       Date:  2008-05-07       Impact factor: 2.846

3.  Contribution of functional KIR3DL1 to ankylosing spondylitis.

Authors:  Ivan V Zvyagin; Ilgar Z Mamedov; Olga V Britanova; Dmitriy B Staroverov; Evgeni L Nasonov; Anna G Bochkova; Anna V Chkalina; Alexei A Kotlobay; Dmitriy O Korostin; Denis V Rebrikov; Sergey Lukyanov; Yuri B Lebedev; Dmitriy M Chudakov
Journal:  Cell Mol Immunol       Date:  2010-09-06       Impact factor: 11.530

Review 4.  The extensive polymorphism of KIR genes.

Authors:  Derek Middleton; Faviel Gonzelez
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

Review 5.  Variable NK cell receptors exemplified by human KIR3DL1/S1.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

6.  Novel insights in the genomic organization and hotspots of recombination in the human KIR locus through analysis of intergenic regions.

Authors:  S Vendelbosch; M de Boer; K van Leeuwen; F Pourfarzad; J Geissler; T K van den Berg; T W Kuijpers
Journal:  Genes Immun       Date:  2014-12-11       Impact factor: 2.676

7.  The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element.

Authors:  Frank Cichocki; Rebecca J Hanson; Todd Lenvik; Michelle Pitt; Valarie McCullar; Hongchuan Li; Stephen K Anderson; Jeffrey S Miller
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

8.  The distal upstream promoter in Ly49 genes, Pro1, is active in mature NK cells and T cells, does not require TATA boxes, and displays enhancer activity.

Authors:  Frances Gays; Sally Taha; Colin G Brooks
Journal:  J Immunol       Date:  2015-04-29       Impact factor: 5.422

9.  Role of KIR3DS1 in human diseases.

Authors:  Christian Körner; Marcus Altfeld
Journal:  Front Immunol       Date:  2012-11-01       Impact factor: 7.561

10.  KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression.

Authors:  Elisa Cisneros; Manuela Moraru; Natalia Gómez-Lozano; Miguel López-Botet; Carlos Vilches
Journal:  Front Immunol       Date:  2012-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.